Safety Profile from Clinical Trials The clinical trials reported that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo for most parameters
The cagrilintide and semaglutide combination (CagriSema) is the flagship application, and the clinical data confirms that the combination produces greater weight loss than either compound alone
And where it ends up determines how it works
A total of 46 healthy female individuals aged 4569 years were enrolled and divided into the placebo group ( n = 23) or treatment group ( n = 23), which ingested one capsule of 500 mg of hydrolyzed fish cartilage, once a day, every night for 90 days
However, the body often responds better to a gradual, steady approach
That's why sourcing from a reputable provider who can guarantee purity isn't just a recommendation